Ocugen, Inc.
NASDAQ:OCGNBiotechnology
+$0.03 today
- Market cap
- $256.75M
- Beta
- 2.21
- P/E (TTM)
- -5.6
- EPS (TTM)
- -$0.22
Volume 5.47M
Average 7.51M
Returns on capital
Ocugen, Inc. management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
557.7%
avg 149.5%
ROIC
-278.6%
avg -112.4%
ROA
-155.9%
avg -97.8%
Analysis
ROE is currently the strongest return metric at 557.7% versus its period average of 149.5%. 1 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Shankar Musunuri | Co-Founder, Chief Executive Officer & Chairman | USD 1.26M | 62 | 1.03M | 0.30% |
Arun Upadhyay | Chief Scientific Officer and Head of Research & Development | USD 703.75K | 44 | 306.20K | 0.09% |
Mohamed Genead | Chief Medical Officer | USD 644.03K | — | — | — |
Vijay Tammara | Chief Development Officer | USD 490.92K | 66 | 0 | <0.01% |
Kristen Craft | Head of People & Culture | — | — | — | — |
Rita Johnson-Greene | CFO & Principal Accounting Officer | — | 49 | — | — |
Chris Clark | VP of Corporate Communications | — | — | — | — |
Paul Staid | Executive Vice President of Operations | — | — | — | — |
Jyothy Pillai | Vice President & Head of Regulatory & Quality | — | — | — | — |
John Kouch | General Counsel | — | — | — | — |
Compensation is shown in the reported currency; data updated Nov 7, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Oct 9, 2026.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
1
$25,830.00
Sells
4
$1.09M
Net Transaction Value
−$1.06M
Net selling
Most Active
Musunuri Shankar
4 transactions
Transactions sorted by date, descending.
| Type | |||
|---|---|---|---|
| Oct 9, 26Oct 9, 2026 | Musunuri Shankar Direct | Sell | $445.3K$445,290.65 |
| Oct 9, 26Oct 9, 2026 | Musunuri Shankar Indirect | Sell | $54.4K$54,400.80 |
| Sep 9, 26Sep 9, 2026 | Musunuri Shankar Direct | Sell | $525K$524,974.24 |
| Sep 9, 26Sep 9, 2026 | Musunuri Shankar Indirect | Sell | $64.1K$64,135.68 |
| Jun 15, 26Jun 15, 2026 | Johnson-Greene Treerita Essalima Direct | Buy | $25.8K$25,830.00 |
Summary
Insiders reported 1 buys worth $25,830.00 and 4 sells worth $1.09M over the last 12 months. That adds up to net selling of $1.06M. Musunuri Shankar was the most active insider with 4 transactions.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | +21.0% | +203.3% (5yr)2 analysts |
| Net Income | N/A | N/A | N/A | N/A2 analysts |
| EBIT | N/A | N/A | N/A | N/A2 analysts |
Analysis
Recent growth has been strongest in Revenue at +21.0% over three years. Forward estimates point to Revenue at +203.3% (5yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Who does Ocugen, Inc. compete with?
Open similar companies to compare how their management teams allocate capital.
Competitors
Peer companies in the same sector
Questions
Management questions
Common questions about OCGN's management, answered from reported figures.
Who manages OCGN?
Ocugen, Inc. (OCGN) lists 10 active executives. The top listed executive is Kristen Craft, Head of People & Culture.
Are OCGN insiders buying or selling?
Recent insider activity shows net buying of $6.62M.
Continue the stock analysis
Jump to another research area for this company.